A carregar...
The Bright Elusive Butterfly of Value in Health Technology Development: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
The current system of health technology development is characterised by multiple misalignments. The "supply" side (innovation policy-makers, entrepreneurs, investors) and the "demand" side (health policy-makers, regulators, health technology assessment, purchasers) operate under...
Na minha lista:
| Publicado no: | Int J Health Policy Manag |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Kerman University of Medical Sciences
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5745872/ https://ncbi.nlm.nih.gov/pubmed/29325407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/ijhpm.2017.65 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|